OUI Inc. International

OUI Inc. International Providing accessible & affordable eye care to those in need through the Smart Eye Camera, the SEC. This is the international official account of OUI Inc.

Some posts are shared with OUI Inc. account (focused more for our Japanese followers)

OUI Inc. Named Top 12 Global Finalist at AIDEA Tech Challenge 2025OUI Inc. is thrilled to announce that we have been sel...
28/11/2025

OUI Inc. Named Top 12 Global Finalist at AIDEA Tech Challenge 2025

OUI Inc. is thrilled to announce that we have been selected as one of the Top 12 global finalists in the Asian Development Bank’s AIDEA Tech Challenge 2025! Chosen from leading innovators around the world, we presented SEC at the AIDEA Tech Challenge Grand Finale on 28 November 2025 at ADB Headquarters in Manila.

The AIDEA Tech Challenge—co-led by ADB and PATH—is a global initiative calling for AI-based screening and diagnostic innovations that align with the WHO Essential Diagnostics List (EDL), the WHO Priority Disease List, and the Priority Bacterial Pathogen List, as well as the national health priorities of countries across Asia and the Pacific.

It was our great pleasure and honor to showcase our technologies on this global stage!

Smart Eye Camera Wins Double Awards (Gold & Silver) at ONE Asia Creative Awards 2025We are proud to announce that the jo...
21/11/2025

Smart Eye Camera Wins Double Awards (Gold & Silver) at ONE Asia Creative Awards 2025

We are proud to announce that the joint project between OUI Inc. and TBWA Hakuhodo — the Smart Eye Camera — has won two awards at the ONE Asia Creative Awards 2025, which recognizes outstanding creativity across the Asia-Pacific region:

Gold Award in the IP & Product Design / Products for Good category

Silver Award in the Creative Use of Technology / Technology for Good category

This project is a collaborative effort by OUI Inc. and TBWA Hakuhodo to showcase the social value and potential of the Smart Eye Camera via creative communication.
This latest recognition builds on our recent achievements, including final selection at Cannes Lions 2025, double Gold at Mad Stars 2025, finalist status at London International Awards 2025, and a Silver & Bronze double at ACC Tokyo Creativity Awards 2025.

For the full list of winners:
https://www.oneclub.org/oneasia/showcase/2025/

Courtesy Visit to the Embassy of the Republic of Mozambique in JapanOn November 11, 2025, OUI Inc. CEO Dr. Eisuke Shimiz...
11/11/2025

Courtesy Visit to the Embassy of the Republic of Mozambique in Japan

On November 11, 2025, OUI Inc. CEO Dr. Eisuke Shimizu, COO Shintaro Nakayama, and Ms. Veronica, OUI Inc.'s intern from Lúrio University currently studying in Japan, paid a courtesy visit to Minister Plenipotentiary Nhalungo at the Embassy of Mozambique in Tokyo.
We had a very fruitful discussion on how we can expand our efforts moving forward!

Our own Dr. Eisuke Shimizu has been selected as one of the JCI (Juniour Chamber International) Ten Outstanding Young Per...
09/11/2025

Our own Dr. Eisuke Shimizu has been selected as one of the JCI (Juniour Chamber International) Ten Outstanding Young Persons (TOYP) winners!

OUI Inc. is very grateful to have moved on to the first pitching round of the Innopreneurs Startup Contest S12 2025 host...
04/11/2025

OUI Inc. is very grateful to have moved on to the first pitching round of the Innopreneurs Startup Contest S12 2025 hosted by Lemon Ideas

We are pleased to announce that the joint project “Smart Eye Camera” by OUI Inc. and TBWA HAKUHODO has won a Silver Awar...
23/10/2025

We are pleased to announce that the joint project “Smart Eye Camera” by OUI Inc. and TBWA HAKUHODO has won a Silver Award in the Creative Innovation category and a Bronze Award in the Design category at the ACC TOKYO CREATIVITY AWARDS, Japan’s largest and most prestigious creative competition.

OUI Inc. is pleased to announce that the joint project “Smart Eye Camera” by OUI Inc. and TBWA\HAKUHODO has won a Silver Award in the…

Smart Eye Camera Selected as a Finalist at the London International Awards 2025!The joint project “Smart Eye Camera” by ...
09/10/2025

Smart Eye Camera Selected as a Finalist at the London International Awards 2025!

The joint project “Smart Eye Camera” by OUI Inc. and TBWA\HAKUHODO has been selected as a finalist in the Pharma & Medical category at the prestigious London International Awards 2025.
Although it did not win the award, this recognition highlights the project’s continued excellence and global impact.

This initiative represents a collaboration between OUI Inc. and TBWA\HAKUHODO, aiming to share the social value and potential of Smart Eye Camera with the world through the power of creativity.
This achievement follows its selection as a finalist in the Pharma category at Cannes Lions 2025, as well as its Gold Awards in the SDGs and Innovation categories at Mad Stars 2025 — another remarkable milestone for the project.

https://x.gd/74gtu

We have an exhibition booth at Bio Japan 2025, taking place at PACIFICO Yokohama from October 8 to 10, 2025!Please stop ...
08/10/2025

We have an exhibition booth at Bio Japan 2025, taking place at PACIFICO Yokohama from October 8 to 10, 2025!
Please stop by and visit us!
https://jcd-expo.jp/en/

On October 2, 2025, OUI Inc.’s COO, Shintaro Nakayama, participated in the Japan-Taiwan Medtech Innovation Night and won...
02/10/2025

On October 2, 2025, OUI Inc.’s COO, Shintaro Nakayama, participated in the Japan-Taiwan Medtech Innovation Night and won first place in the pitch contest featuring startups from Japan and Taiwan!

https://behealthjp.peatix.com/

In August 2025, our Medical Affairs & Research Associate, Dr. Rohan Jeetendra Khemlani, collaborated with Divya Jyoti Tr...
02/10/2025

In August 2025, our Medical Affairs & Research Associate, Dr. Rohan Jeetendra Khemlani, collaborated with Divya Jyoti Trust's Tejas Eye Hospital, and took the lead in his new study, using the in the rural & tribal villages near Mandvi in Gujarat, India.

Groups of people would be sent out to the villages to perform door-to-door visual tests and anyone with inadequate results or other complaints would be referred to an outpatient centre that would be set up in the village's local elementary/primary school for more extensive testing, which included visual acuity, refraction, blood pressure, blood glucose measurements, and anterior segment imaging with the Smart Eye Camera. From there, if further testing or intervention was needed, then the patient would be referred to Tejas Eye Hospital for more comprehensive care.

OUI Inc. is extremely grateful to Divya Jyoti Trust's Tejas Eye Hospital and its entire staff for all of the help and support. We look forward to a fruitful long-term collaboration.

At the international advertising festival MAD STARS 2025, held in Busan, South Korea from August 27–29, 2025, our jointl...
02/09/2025

At the international advertising festival MAD STARS 2025, held in Busan, South Korea from August 27–29, 2025, our jointly planned and produced project with TBWA\HAKUHODO, “Smart Eye Camera”, received two Gold Award:

• SDGs (Sustainable Development Goals) Stars — GOLD: Recognized as an innovative initiative utilizing cutting-edge technology.
• Innovation Stars — GOLD: Acknowledged as a socially impactful project contributing to the achievement of the SDGs.

MAD STARS is an annual global festival in South Korea celebrating marketing and digital content from around the world. This year’s theme was “AI-versing: The Era of AI-driven Advertising and Marketing.”

From August 27 to 29, at the Nigerian Ophthalmologic Society (NOS) 2025 held in Kano, Nigeria, OUI Inc. COO Shintaro Nak...
29/08/2025

From August 27 to 29, at the Nigerian Ophthalmologic Society (NOS) 2025 held in Kano, Nigeria, OUI Inc. COO Shintaro Nakayama participated and delivered a presentation on the Smart Eye Camera, as well as showcased our activities at the exhibition booth.

住所

510 DF Building, 2-2-8, Minami-Aoyama, Minato-ku
Tokyo
107-0062

ウェブサイト

https://www.facebook.com/ouiinc

アラート

OUI Inc. Internationalがニュースとプロモを投稿した時に最初に知って当社にメールを送信する最初の人になりましょう。あなたのメールアドレスはその他の目的には使用されず、いつでもサブスクリプションを解除することができます。

共有する

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

カテゴリー